Role of retinoic receptors in lung carcinogenesis

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Bogos, Krisztina ^a,b,c   Renyi Vamos, Ferenc ^a,c   Kovacs, Gabor ^b,c   Tovari, Jozsef ^a,c   Dome, Balazs ^a,b,c  

^a Tumor Biology   (Hungary)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANETHOLE TRITHIONE; BETA CAROTENE; FENRETINIDE; ISOTRETINOIN; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOL; RETINOL PALMITATE; ANTINEOPLASTIC AGENT;

AMINO TERMINAL SEQUENCE; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; CHROMOSOME REARRANGEMENT; CLINICAL TRIAL; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG EFFICACY; DRUG MECHANISM; EPIGENETICS; GENE DELETION; GENE SILENCING; HUMAN; LIGAND BINDING; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MESOTHELIOMA; METAPLASIA; PRIORITY JOURNAL; RETINOL DEFICIENCY; REVIEW; SECOND CANCER; TRANSCRIPTION INITIATION; UNSPECIFIED SIDE EFFECT; ANIMAL; CELL TRANSFORMATION; GENETIC EPIGENESIS; LUNG TUMOR; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; HUMANS; LUNG NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOIDS; SIGNAL TRANSDUCTION;

EID: 52949134871     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-18     Document Type: Review

References (61)

1. The care of the lung cancer patient in the 21st century: a new age. W Smith FR Khuri, Semin Oncol 2004 31 11 15 10.1053/j.seminoncol.2004.02.012 15124128
2. Retinoid receptor cross-talking respiratory epithelium cancer chemoprevention. MV Karamouzis AG Papavassiliou, Trends Molecular Medecine 2005 1 10 16 10.1016/j.molmed.2004.11.006
3. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). MB Sporn NM Dunlop DL Newton JM Smith, Fed Proc 1976 35 6 1332 1338 770206
4. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. R Lotan, J Natl Cancer Inst 1995 87 1655 1657 10.1093/jnci/87.22.1655 7473809
5. Retinoids in chemoprevention and differentiation therapy. LA Hansen CC Sigman F Andreola SA Ross GJ Kelloff LM De Luca, Carcinogenesis 2000 7 1271 1279 10.1093/carcin/21.7.1271
6. The steroid and thyroid hormone receptor superfamily. RM Evans, Science 1988 240 889 895 10.1126/science.3283939 3283939
7. A decade of molecular biology of Retinoic Acid. P Chambon, Faseb J 1996 10 940 954 8801176
8. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. G Allenby MT Bocquel M Saunders S Kazmer J Speck M Rosenberger A Lovey P Kastner JF Grippo P Chambon Levin AA, Proc Natl Acad Sci USA 1993 90 30 34 8380496 10.1073/pnas.90.1.30
9. Retinoids and their receptors in cancer development and chemoprevention. SY Sun R Lotan, Critical Reviews in Oncology/Hematology 2002 41 41 55 10.1016/S1040-8428(01)00144-5 11796231
10. Targeted histone deacetylase inhibition for cancer therapy. DM Vigushin RC Coombes, Curr Cancer Drug Targets 2004 2 205 218 10.2174/1568009043481560
11. Synthetic retinoids and their nuclear receptors. MI Dawson, Curr Med Chem Anticancer Agents 2004 3 199 230 10.2174/1568011043352975
12. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. WJ Petty N Li A Biddle, J Natl Cancer Inst 2005 97 22 1645 1651 16288117
13. Retinoids: present role and future potential. TR Evans SB Kaye, Br J Cancer 1999 80 1 8 10.1038/sj.bjc.6690312 10389969
14. Multiplicity generates diversity in the retinoic acid signalling pathways. M Leid P Kastner P Chambon, Trends Biochem Sci 1992 10 427 433 10.1016/0968-0004(92)90014-Z 1333659
15. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). J Whang-Peng PA Bunn Jr C Kao-Shan C Lee DN Carney A Gazdar JD Minna, Cancer Genet Cytogenet 1982 2 119 134 10.1016/0165-4608(82)90077-2
16. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). J Whang-Peng CS Kao-Shan EC Lee PA Bunn DN Carney AF Gazdar JD Minna, Science 1982 215 181 182 10.1126/science.6274023 6274023
17. Implication of RARB in epidermoid (Squamous) lung cancer. B Houle F Leduc WE Bradley, Genes Chromosomes Cancer 1991 5 358 366 10.1002/gcc.2870030506 1665705
18. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo:implications for lung cancer development. XC Xu G Sozzi JS Lee JJ Lee U Pastorino S Pilotti JM Kurie WK Hong R Lotan, J Natl Cancer Inst 1997 89 624 629 10.1093/jnci/89.9.624 9150186
19. Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acidreceptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. J Ayoub R Jean-François Y Cormier D Meyer Y Ying P Major C Desjardins WE Bradley, J Clin Oncol 1999 17 11 3546 3552 10550153
20. High frequency of retinoic acid receptor beta abnormalities in human lung cancer. JF Gebert N Moghal JV Frangioni DJ Sugarbaker BG Neel, Oncogene 1991 6 1859 6 1717924
21. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. XC Xu JY Ro JS Lee DM Shin WK Hong R Lotan, Cancer Res 1994 54 3580 7 8012985
22. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. M Widschwendter J Berger G Daxenbichler E Müller-Holzner A Widschwendter A Mayr C Marth AG Zeimet, Cancer Res 1997 57 4158 61 9331065
23. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. E Picard C Seguin N Monhoven C Rochette-Egly J Siat J Borrelly Y Martinet N Martinet JM Vignaud, J Natl Cancer Inst 1999 91 1059 66 10.1093/jnci/91.12.1059 10379969
24. Retinoic acid receptor and retinoid X receptor alterations in lung cancerprecursor lesions. N Martinet F Alla G Farré T Labib H Drouot R Vidili E Picard MP Gaube D Le Faou J Siat J Borelly P Vermylen T Bazarbachi JM Vignaud Y Martinet, Cancer Res 2000 60 2869 2875 10850430
25. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. SB Baylin M Esteller MR Rountree KE Bachman K Schuebel JG Herman, Hum Mol Genet 2001 10 687 92 10.1093/hmg/10.7.687 11257100
26. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. AK Virmani A Rathi S Zöchbauer-Müller N Sacchi Y Fukuyama D Bryant A Maitra S Heda KM Fong F Thunnissen JD Minna AF Gazdar, J Natl Cancer Inst 2000 92 1303 1307 10.1093/jnci/92.16.1303 10944551
27. Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer. RL Momparler DY Bouffard LF Momparler J Dionne K Belanger J Ayoub, Anticancer Drugs 1997 8 358 68 10.1097/00001813-199704000- 00008 9180389
28. Chemoprevention of tumors: the role of RAR-beta. S Toma L Emionite G Fabia N Spadini L Vergani, Int J Biol Markers 2003 18 78 81 12699070
29. Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. E Garattini M Gianni M Terao, Curr Pharm Des 2004 10 433 448 10.2174/1381612043453351 14965204
30. The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer. J Brabender KD Danenberg R Metzger PM Schneider RV Lord S Groshen DD Tsao-Wei J Park D Salonga AH Hölscher PV Danenberg, Clin Cancer Res 2002 8 438 443 11839661
31. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. DE Ayer QA Lawrence RN Eisenman, Cell 1995 80 767 776 10.1016/0092-8674(95)90355-0 7889570
32. Histone deacetylase activity is required for full transcriptional repression by mSin3A. CA Hassig TC Fleischer AN Billin SL Schreiber DE Ayer, Cell 1997 89 341 347 10.1016/S0092-8674(00)80214-7 9150133
33. RARbeta1': primed to fight retinoid resistance in lung carcinogenesis. AL Sabichi X Xu SM Lippman, J Natl Cancer Inst 2005 97 1632 1633 16288110
34. Cancer chemoprevention drug targets. K Krishnan S Campbell F Abdel-Rahman S Whaley WL Stone, Curr Drug Targets 2003 4 45 54 10.2174/1389450033347028 12528989
35. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. U Pastorino M Infante M Maioli G Chiesa M Buyse P Firket N Rosmentz M Clerici E Soresi M Valente, J Clin Oncol 1993 7 1216 1222
36. Beta-carotene and the higher risk of lung cancer. U Pastorini, J Natl Cancer Inst 1997 89 456 457 10.1093/jnci/89.6.456 9091650
37. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. XD Wang C Liu RT Bronson DE Smith NI Krinsky M Russell, J Natl Cancer Inst 1999 91 60 66 10.1093/jnci/91.1.60 9890171
38. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. N van Zandwijk O Dalesio U Pastorino N de Vries van Tinteren, J Natl Cancer Inst 2000 92 977 986 10.1093/jnci/92.12.977 10861309
39. Chemoprevention of lung cancer-from biology to clinical reality. RC Winterhalder FR Hirsch GK Kotantoulas WA Franklin PA Bunn, Ann Oncol 2004 2 185 196 10.1093/annonc/mdh051 14760107
40. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. S Lam X Xu H Parker-Klein JC Le Riche C Macaulay M Guillaud A Coldman AF Gazdar R Lotan, Int J Oncol 2003 23 6 1607 1613 14612933
41. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. FR Khuri R Lotan BL Kemp SM Lippman H Wu L Feng JJ Lee CS Cooksley B Parr E Chang GL Walsh JS Lee WK Hong XC Xu, J Clin Oncol 2000 15 2798 2804
42. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. FR Khuri H Wu JJ Lee BL Kemp R Lotan SM Lippman L Feng WK Hong XC Xu, Clin Cancer Res 2001 4 861 867
43. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. JS Kim H Lee H Kim YM Shim J Han J Park DH Kim, J Clin Oncol 2004 22 3443 3450 10.1200/JCO.2004.11.135 15277540
44. Retinoids in lung cancer: friend, foe, or fellow traveler? FR Khuri R Lotan, J Clin Oncol 2004 22 3435 3437 10.1200/JCO.2004.05.947 15277536
45. Selective retinoids and rexinoids in cancer therapy and chemoprevention. FC Zusi MV Lorenzi V Vivat-Hannah, Drug Discov Today 2002 7 1165 1174 10.1016/S1359-6446(02)02526-6 12547017
46. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study in A/J mice at low doses: a pilot study. AR Dahl IM Grossi DP Houchens LJ Scovell ME Placke AR Imondi GD Stoner LM De Luca D Wang JL Mulshine, Clin Cancer Res 2000 6 8 3015 3024 10955779
47. Aerosolized delivery and lung cancer prevention: pre-clinical models showpromise. MJ Spinella E Dmitrovsky, Clin Cancer Res 2000 8 2963 2964 10955769
48. Retinoid receptors mRNA levels in normal bronchial mucosa and in lung cancer cell lines. K Bogos L Bonnard N Noel F Claudot G Grosdidier J Siat JM Vignaud Y Martinet M Martinet, Lung Cancer 2004 45 Suppl 3 abstract 15505910
49. Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. MA Ortiz Y Bayon FJ Lopez-Hernandez FJ Piedrafita, Drug Resist Updat 2002 5 162 175 10.1016/S1368-7646(02)00050-X 12237083
50. Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer. MJ Edelman R Smith P Hausner LA Doyle K Kalra J Kendall M Bedor S Bisaccia, J Clin Oncol 2005 23 5774 5778 10.1200/JCO.2005.14.373 16110034
51. Bexarotene in combination with chemotherapy fails to prolong survival in patients with advanced non-small-cell lung cancer: results from the SPIRIT I and II trials. P Tyagi, Clin Lung Cancer 2005 7 1 17 9 16098239
52. RAR and RXR modulation in cancer and metabolic disease. L Altucci MD Leibowitz KM Ogilvie AR de Lera H Gronemeyer, Nat Rev Drug Discov 2007 10 793 810 10.1038/nrd2397 17906642
53. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. SY Sun P Yue MI Dawson B Shroot S Michel WW Lamph RA Heyman M Teng RA Chandraratna K Shudo WK Hong R Lotan, Cancer Res 1997 57 4931 4939 9354460
54. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. SY Sun P Yue X Chen WK Hong R Lotan, Cancer Res 2002 62 2430 2436 11956107
55. Receptor selective synthetic retinoids as potential cancer chemotherapy agents. DL Crowe, Curr Cancer Drug Targets 2002 2 77 86 10.2174/1568009023333935 12188922
56. Retinoids in cancer therapy and chemoprevention: promise meets resistance. SJ Freemantle MJ Spinella E Dmitrovsky, Oncogene 2003 22 7305 7315 10.1038/sj.onc.1206936 14576840
57. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. Alpha-tocopherol, Beta-Carotene Cancer Prevention Study Group, N Engl J Med 1994 330 1029 35 10.1056/ NEJM199404143301501 8127329
58. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. GS Omenn GE Goodman MD Thornquist J Balmes MR Cullen A Glass JP Keogh FL Meyskens B Valanis JH Williams S Barnhart S Hammar, N Engl J Med 1996 334 1150 5 10.1056/NEJM199605023341802 8602180
59. Lack of effect of long term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. CH Hennekens JE Buring JE Manson M Stampfer B Rosner NR Cook C Belanger F LaMotte JM Gaziano PM Ridker W Willett R Peto, N Engl J Med 1996 334 1145 9 10.1056/ NEJM199605023341801 8602179
60. N-(4-Hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. JM Kurie JS Lee FR Khuri L Mao RC Morice JJ Lee GL Walsh A Broxson SM Lippman JY Ro BL Kemp D Liu HA Fritsche X Xu R Lotan WK Hong, Clin Cancer Res 2000 6 2973 9 10955773
61. Randomized phase III intergroup trial of isotertinoin to prevent second primary tumors in stage I non-small-cell lung cancer. SM Lippman JJ Lee DD Karp EE Vokes SE Benner GE Goodman FR Khuri R Marks RJ Winn W Fry SL Graziano DR Gandara G Okawara CL Woodhouse B Williams C Perez HW Kim R Lotan JA Roth WK Hong, J Natl Cancer Inst (Bethesda) 2001 93 605 18 10.1093/jnci/93.8.605